We are EMBL: Mary Barlow on managing change
Mary Barlow shares her insights on change management and her new role as Head of Major Initiatives at EMBL-EBI.
PEOPLE & PERSPECTIVES2025
people-perspectivesperspectives
We are EMBL: Victoria Yan on open science and how it has transformed the way we do research
Victoria Yan, Open Science & Research Information Specialist, talks about the importance of open science, the challenges she has faced in her career, and what she enjoys about working at EMBL
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectives
We are EMBL: Carolin Sauer on supporting cancer research
Postdoctoral researcher Carolin Sauer is leveraging long-read sequencing to develop new detection methods for various cancers.
LAB MATTERSPEOPLE & PERSPECTIVES2023
lab-matterspeople-perspectivesresearch-highlights
Europe PMC contributes to the Open Global Data Citation Corpus
The Open Global Data Citation Corpus will become a central place for research data citations, and include accession numbers supplied by Europe PMC.
2023
announcements
Machine learning to identify and prioritise drug targets
Open Targets is using artificial intelligence and machine learning to identify and prioritise drug targets.
SCIENCE & TECHNOLOGY2023
sciencescience-technologytechnology-and-innovation
EMBL-EBI databases considered critical to life sciences
Open data resources that enable global research and development recognised by the Global Biodata Coalition.
2022
announcementsscience
Open science for climate justice
Our experts discuss the importance of open science for food security and preserving global biodiversity.
2022
perspectivesscience
Setting priorities for preprints and open science
Newly appointed member of the ASAPbio Board of Directors, EMBL Group Leader Gautam Dey speaks about preprints, data management, and open science.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
AlphaFold: where will the next AI breakthrough come from?
Ewan Birney, Deputy Director General of EMBL and Director of EMBL-EBI, reveals the key factors that enabled AlphaFold to change the world of biology.
PEOPLE & PERSPECTIVES2022
people-perspectivesperspectivesscience
CNest: a new method for copy number variation analysis
A new method for the robust analysis of copy number variation and used UK Biobank data to identify links between genome and disease.
SCIENCE & TECHNOLOGY2022
research-highlightssciencescience-technology
Welcome: Maria Papanikolaou
EMBL’s new archive and records manager, Maria Papanikolaou, explains the dual role she and an additional colleague will have in the Office of Science Information Management.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
Fergal Martin – Eukaryotic Annotation Team Leader
Fergal Martin discusses the importance of open access data and his work in different biodiversity initiatives
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
Organisations should embrace open science faster – interview with Prof. Dame Janet Thornton
Janet Thornton, the inaugural winner of the FEBS Journal Open Science Award, explains the importance and impact of open science.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectivesperspectives
Europe PMC: Harnessing the power of text mining to accelerate life sciences research
How text mining collaborations benefit our research, data resources, and the wider scientific community.
SCIENCE & TECHNOLOGY2022
sciencescience-technologytechnology-and-innovation
Peter Harrison – Genome Analysis Team Leader
Peter Harrison discusses the importance of data accessibility and his passion for biodiversity and agricultural genomics.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
“If you want science to move forward, you have to share it”
EMBO Director Fiona Watt discusses preprints, data sharing, and evaluation in light of EMBL’s new Open Science policy
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
The MANE collaboration: working together to support genome science
Researchers from the MANE collaboration bring you the most comprehensive human genome annotation dataset to date.
SCIENCE & TECHNOLOGY2022
research-highlightssciencescience-technology
Genomic sequencing aids the global Tuberculosis fight
Zamin Iqbal and his team are working with researchers all over the globe to help put a stop to Tuberculosis
SCIENCE & TECHNOLOGY2022
perspectivessciencescience-technology
Darwin Tree of Life at EMBL-EBI: reaching the first major milestone
Our researchers highlight their contributions to the Darwin Tree of Life project and how new genome annotations helps to further biodiversity research
SCIENCE & TECHNOLOGY2022
announcementssciencescience-technology
Safeguarding African biodiversity through genomics
The African BioGenome Project aims to safeguard biodiversity and build bioinformatics capacity across Africa
SCIENCE & TECHNOLOGY2022
perspectivessciencescience-technology
Pfizer joins the Open Targets consortium
Open Targets, a consortium focused on drug target identification, prioritisation, and validation, announced today that Pfizer has joined as a partner.
CONNECTIONS2022
announcementsconnectionsscience
The Earth Biogenome Project: on track and ready to ramp up
On track to reach an ambitious goal of 3,000 genomes sequenced by the end of 2022, what’s next for the Earth Biogenome Project?
SCIENCE & TECHNOLOGY2022
announcementssciencescience-technology
Welcome: Melissa Harrison
Melissa Harrison joins EMBL-EBI as the new Team Leader of Literature Services. We found out more about her plans for open access publishing and Europe PMC.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
Open science at EMBL: a transparent way of working
EMBL announces the release of its new Open Science Policy, contributing to positive culture change across the life sciences.
LAB MATTERS2021
lab-matters
Welcome: Tudor Groza
Tudor Groza joins EMBL-EBI as our new Phenomics Team Lead. We found out from Tudor exactly what this new role will entail
LAB MATTERSPEOPLE & PERSPECTIVES2021
lab-matterspeople-perspectives
Open data on the rise: the value of EMBL-EBI data resources
Independent study reveals that EMBL-EBI open data resources are critical for the life sciences.
LAB MATTERSSCIENCE & TECHNOLOGY2021
lab-mattersscience-technology
BY-COVID – a new EU project for pandemic preparedness
The BY-COVID project aims to make infectious disease data, including COVID-19, openly available to everyone.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
The human genome, data sharing, and drug discovery: a career profile with Ian Dunham
Ian Dunham walks us through his career so far including working on the human genome project, seeing his work on the cover of Nature and his current role as Director of Open Targets.
LAB MATTERSPEOPLE & PERSPECTIVES2021
lab-matterspeople-perspectives
Organoids and machine learning: image analysis software developed during lockdown
MOrgAna is an open source, user-friendly, modular software that is able to analyse organoids with machine learning.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
3D-Beacons Network: protein structure data, all in one place
3D-Beacons Network acts as a one-stop shop for protein structures by combining and standardising data from several providers.
CONNECTIONS2021
connectionsscience
DeepMind and EMBL release the most complete database of predicted 3D structures of human proteins
Partners use AlphaFold, the AI system recognised last year as a solution to the protein structure prediction problem, to release more than 350,000 protein structure predictions including the entire human proteome to the scientific community.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Accessible 3D protein models to accelerate scientific discovery
DeepMind and EMBL-EBI to make millions of protein structure predictions freely available to the scientific community.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
Great expectations – the potential impacts of AlphaFold DB
A discussion of the applications that AlphaFold DB may enable and the possible impact of the resource on science and society.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
The PROTACtable genome – a new route to drug discovery
Researchers establish a framework for identifying new drugs capable of exploiting a cell’s own machinery.
SCIENCE & TECHNOLOGY2021
sciencescience-technology
The value of open data for Latin American science
Scientists from the CABANA project explore how open data is benefiting global research efforts.
CONNECTIONS2021
connectionsscience
Show your support for open COVID-19 data
Open letter galvanises life science community in support of open COVID-19 data
EMBL ANNOUNCEMENTSLAB MATTERS2021
embl-announcementslab-matters
Repurposing bioinformatics tools to tackle the pandemic
Bioinformaticians at EMBL-EBI and beyond are adapting computational tools to investigate coronavirus genomes and proteins.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Bringing AI out of the black box
Why should researchers make artificial intelligence more transparent and how can they do it?
LAB MATTERSSCIENCE & TECHNOLOGY2020
lab-mattersscience-technology
EOSC: shaping Europe’s digital future
EMBL’s Rupert Lück is engaged in developing the European Open Science Cloud (EOSC): the infrastructure that will support the future of data sharing and analysis in Europe.
CONNECTIONSLAB MATTERS2020
connectionslab-matters
Open data sharing accelerates COVID-19 research
Open access data benefits millions of scientists around the world and is essential for a rapid response to the COVID-19 pandemic.
SCIENCE & TECHNOLOGY2020
sciencescience-technology
Achieving personalised therapeutics
A decadal roadmap points the way to cell-based medicine for Europe
LAB MATTERSSCIENCE & TECHNOLOGY2020
lab-mattersscience-technology
Welcome: Bastian Drees
Bastian Drees is a biophysicist turned librarian, who joined EMBL in January as the new Head of Library. Here, he discusses the changing role of libraries and how they can help scientists organise and share their results.
LAB MATTERSPEOPLE & PERSPECTIVES2020
lab-matterspeople-perspectives
Marking 40 years of the Szilárd Library
The Szilárd Library celebrates its 40th anniversary on 20 November 2019.
LAB MATTERS2019
lab-matters
Facilitating transcontinental human data exchange
Federated data sharing will now be possible on an unprecedented scale
SCIENCE & TECHNOLOGY2019
sciencescience-technology
The future of scientific publishing
Ioanna Ydraiou and Bernd Pulverer spoke about their view of challenges and opportunities of OA.
LAB MATTERS2018
lab-matters
Open access: transforming science
EMBL’s new open access policy aims to make EMBL research widely and freely accessible.
LAB MATTERS2015
lab-matters
Become a member of Euro-BioImaging
Euro-BioImaging, the pan-European open access research infrastructure for biological and medical imaging technologies, invites leading European imaging facilities to submit proposals to participate. Applications to become a Euro-BioImaging node will be reviewed by a board of independent…
CONNECTIONSLAB MATTERS2013
connectionslab-matters
Better imaging from bench to bedside
From microscopy to computer tomography (CT) scans, imaging plays an important role in biological and biomedical research, but obtaining high-quality images often requires advanced technology and expertise, and can be costly. Euro-BioImaging, a project which launches its preparatory phase today,…
SCIENCE & TECHNOLOGY2010
sciencescience-technology
Open access to large-scale drug discovery data
The Wellcome Trust has awarded £4.7 million (€5.8 million) to EMBL’s European Bioinformatics Institute (EMBL-EBI) to support the transfer of a large collection of information on the properties and activities of drugs and a large set of drug-like small molecules from the publicly listed…
LAB MATTERS2008
lab-matters
EMBL-EBI and collaborators win bid to run UK PubMed Central
Scientists will be able to access a vast collection of biomedical research at the touch of a button thanks to a major new initiative that aims to promote the free transfer of ideas in a bid to speed up scientific discovery. Based on a model currently used in the United States, UK PubMed Central…
EMBL ANNOUNCEMENTSLAB MATTERS2006
embl-announcementslab-matters
A brighter future for Europe’s favourite molecular biology software package
EMBOSS, the European Molecular Biology Open Software Suite, has received a vital funding boost from the UK Biotechnology and Biological Sciences Research Council (BBSRC) that will guarantee its continued maintenance under an open source license for the next three years. This ends two years of…
CONNECTIONSLAB MATTERS2006
connectionslab-matters
No results found